Clinical Trial Update: Oxytocin and Alcohol Withdrawal and Dependence [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining oxytocin for alcohol withdrawal and dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholism
• Substance-related Disorders

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Alcoholism, Substance-Related Disorders | Phase 3 | Status: COMPLETED